Stories From This Week's Episode
July 20, 2012
Just a week before the International AIDS Conference takes place in Washington, DC -- the first time in 22 years that it will be held in the U.S. -- the drug Truvada has been approved for HIV prevention by the Food and Drug Administration. The news brings hope to those in high risk categories, but there are also concerns that it could lead to a return of risky behaviors. Can Yahoo's new CEO Marissa Mayer balance running the high-profile tech company with being a new mother? Mayer has proven to be innovative as a former lead engineer and vice president at Google, but there's speculation over whether the 37-year-old Silicon Valley star can save the faltering Internet giant. As embattled San Francisco Sheriff Ross Mirkarimi's misconduct trial continues this week with testimony from his wife, Eliana Lopez, Mayor Ed Lee himself is the subject of an investigation for possible perjury by the Ethics Commission. This comes as a vote on Lee's major development deal with the California Pacific Medical Center is put on hold for two weeks and he encounters a backlash by the Board of Supervisors and the public to his push for a stop-and-frisk policy.
- Lisa Aliferis, KQED State of Health Blog
- Jolie O'Dell, VentureBeat
- Rachel Gordon, San Francisco Chronicle
Attorney Carolyn House Stewart is the leader of the world's oldest and largest sorority for college educated African American women. The group holds their conference in San Francisco next week for the first time sine the 1950s.
Also on KQED.org this week ...
The Most Important New California Laws of 2015
More than 900 new laws are hitting the books in 2015. Here's our annual list of the most important and/or interesting, as picked by KQED news, science, health, and politics and government editors.
"Boomtown" History of the San Francisco Bay Area
KQED's "Boomtown" series will seek to identify what is happening in real time in the current boom, and also draw out the causes and possible solutions to the conflicts and pressures between the old and the new.